Top compounds associated with response to ARL6IP4


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.055 0.1
mRNA paclitaxel gCSI pan-cancer AAC -0.075 0.1
mRNA Erlotinib UHNBreast pan-cancer AAC -0.41 0.1
mRNA IU1 CTRPv2 pan-cancer AAC -0.058 0.1
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC -0.11 0.1
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA ouabain CTRPv2 pan-cancer AAC 0.052 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.1
mRNA ML162 CTRPv2 pan-cancer AAC 0.05 0.1
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.11 0.1
Download CSV